 Injection of cardiomyogenic and/or angiogenic stem cells have been proposed as alternatives to existing treatments.For cardiovascular application, skeletal myoblasts are of great interest as they can be easily isolated and are associated with high proliferation rate.These cells have also been demonstrated to be hypoxia-resistant.